Table: begin end state 1 6 cytoplasmic 7 26 transmembrane 27 32 non-cytoplasmic 33 52 transmembrane 53 89 cytoplasmic 90 111 transmembrane 112 116 non-cytoplasmic 117 139 transmembrane 140 159 cytoplasmic 160 183 transmembrane 184 188 non-cytoplasmic 189 209 transmembrane 210 220 cytoplasmic 221 239 transmembrane 240 254 non-cytoplasmic 255 276 transmembrane 277 283 cytoplasmic 284 305 transmembrane 306 324 non-cytoplasmic 325 345 transmembrane 346 364 cytoplasmic 365 385 transmembrane 386 464 non-cytoplasmic 465 484 transmembrane 485 509 cytoplasmic 510 529 transmembrane 530 541 non-cytoplasmic 542 566 transmembrane 567 572 cytoplasmic 573 593 transmembrane 594 638 non-cytoplasmic 639 660 transmembrane 661 690 cytoplasmic
Input: >RR42_RS20515 MNRIGQHLVWLAVAILGAFAFATVALSRGEAVSALWIVVAAICIYLIAYRYYSKFIAEKV MQLDPKRMTPAWRHNDGLDYVPTNKAVLFGHHFAAIAGAGPLVGPVLAAQMGYMPGMLWI LAGVVFAGAVQDFMVLFISTRRDGRSLGDLIKSEMGTVPGMIALFGCFMIMIIILAVLAL IVVKALAGSPWGTFTVGVTIPIALFMGIYTRYIRPGRIGEVSVIGFVLLMLAIIGGQYVH ESAVLAPLFTYDGKALTWMLIIYGFIAAVLPVWLLLAPRDYLSTFLKIGTIIALAIGILI VAPELKMPAFTQFAKGGGPVWSGNLFPFLFITIACGAVSGFHALISSGTTPKLLESEAHM RFIGYGAMLAESFVAIMALVAASVIEPGVYFAMNSPAAVIGTSPESVAQVVSGWGFVITP DVLIQTAKDVGENSIISRAGGAPTLAVGIAHILHQVVGGQAMMAFWYHFAILFEALFILT AVDAGTRAGRFMLQDLLGSFVPSFRRTDSLPANLIATALTVSFWGYFLYQGVVDPLGGIN TLWPLFGISNQMLAAVALVLGTCVLVKMKRGQYAWVTLVPTIWLLICTLTAGWQKLFDAD PKVSFLTHAAKFSDAIAQGKVLAPAKSMEQMHRIVFNDYLDAGLCALFMFVVLSIVFYGF KTAMKARAENRPTDRETPFEPMPASASAQH
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server